Using MRI to Study Blood Flow in Brain Tumors
Author Information
Author(s): Darpolor Moses M., Molthen Robert C., Schmainda Kathleen M.
Primary Institution: Medical College of Wisconsin
Hypothesis
Can dynamic susceptibility contrast-MRI (DSC-MRI) detect vascular abnormalities in a brain tumor model and reflect the effects of dexamethasone treatment?
Conclusion
Dexamethasone treatment reduces vascular density and tortuosity, which are linked to abnormal perfusion in brain tumors.
Supporting Evidence
- Relative cerebral blood volume was significantly reduced on the third day of dexamethasone treatment compared to the fifth day.
- Vascular density and tortuosity were significantly reduced in tumors treated with dexamethasone compared to saline-treated tumors.
- Dexamethasone treatment resulted in reduced vessel area in tumor regions compared to saline-treated regions.
Takeaway
This study shows that a special type of MRI can help us see how blood flow changes in brain tumors when treated with a medicine called dexamethasone.
Methodology
The study involved two cohorts of rats with gliosarcoma, one treated with dexamethasone and the other with saline, and used DSC-MRI to measure blood flow and vascular characteristics.
Potential Biases
Potential bias in the interpretation of imaging results and the small sample size may affect the reliability of the conclusions.
Limitations
The study was conducted on a small number of animal models, which may limit the generalizability of the findings.
Participant Demographics
Fisher 344 adult male rats, weighing 250-300 g.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website